Michael Cooper
Profile
Michael Cooper served as the Chief Medical Officer at Constellation Pharmaceuticals, Inc. Prior to that, he obtained an undergraduate degree from Duke University.
Former positions of Michael Cooper
| Companies | Position | End |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Michael Cooper
| Duke University | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Michael Cooper
